Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenCitations
Works that cite this article, indexed by OpenCitations.
Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury
BMC Complementary Medicine and Therapies 25(1) (2025)
Kasra Shahsavari; Shireen Shams Ardekani; Mohammad Reza Shams Ardekani; Majid Mokaber Esfahani; Hossein Kazemizadeh; Tannaz Jamialahmadi; Mehrdad Iranshahi; Mahnaz Khanavi; Maede Hasanpour
Lactobacillus rhamnosus GG Combined with Metformin Alleviates Alcohol-Induced Liver Inflammation in Mice by Maintaining the Intestinal Barrier and Regulating Treg/Th1 Cells
Journal of Medicinal Food 28(4) (2025)
Yin Zhu; Yizhi Pan; Xiaozhi Wang; Li Wei; Lujian Zhu; Yu Guo; HaoRan Jin; Yingying Gu; Yaqin Wang; Yongping Chen; Lanman Xu
Effects of silymarin on insulin resistance and sensitivity: A systematic review and meta-analysis of randomized controlled trials
Diabetes Research and Clinical Practice 220 (2025)
Shao Yin; Fengya Zhu; Ying Liu; Qiu Chen
Effects of silymarin supplementation in late pregnancy and lactation on reproductive performance, colostrum quality, blood biochemistry and inflammation levels of sows
Tropical Animal Health and Production 57(2) (2025)
Guanglei Cong; Shuangshuang Xia; Chunxue Liu; Junbo Li; Ifen Hung; Lili Zhang; Shuaipeng Guo; Bo Zhao
Efficacy of Hypoglycemic Agents in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A Systematic Review and Network Meta‐Analysis
Journal of Evidence-Based Medicine 18(2) (2025)
Qiao Ren; Yao Tan; Guixiang Zhang; Yuzhao Dai; Lidan Yang; Yunmo Wu; He He; Jie Chen
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease
Cochrane Database of Systematic Reviews 2025(6) (2025)
Caie Wang; Yiyang Shang; Ghid Kanaan; Lu Chai; Hui Li; Xingshun Qi
The Evaluation of Effective Drugs for the Treatment of Non-Alcoholic Fatty Liver Disease: A Aystematic Review and Network Meta-Analysis
Advanced Pharmaceutical Bulletin 10(4) (2020)
Ramin Jalili; Mohammad Hossein Somi; Hossein Hosseinifard; Fatemeh Salehnia; Morteza Ghojazadeh; Nima Makhdami; Masoud Shirmohammadi
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review
Annals of Medicine 54(1) (2022)
Alessio Aghemo; Olga P. Alekseeva; Francesco Angelico; Igor G. Bakulin; Natalia V. Bakulina; Dmitry Bordin; Alexey O. Bueverov; Oxana M. Drapkina; Anton Gillessen; Elvira M. Kagarmanova; Natalia V. Korochanskaya; U. A. Kucheryavii; Leonid B. Lazebnik; Maria A. Livzan; Igor V. Maev; Anatolii I. Martynov; Marina F. Osipenko; Evgenii I. Sas; Antonina Starodubova; Yurii P. Uspensky; Elena V. Vinnitskaya; Emilia P. Yakovenko; Alexey A. Yakovlev
Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis
Frontiers in Endocrinology 12 (2021)
Jingxuan Lian; Jianfang Fu
Protective Effects of Silymarin Against D-Gal/LPS-Induced Organ Damage and Inflammation in Mice
Drug Design, Development and Therapy Volume 15 (2021)
Xin Zhao; Haoxiang Wang; Yue Yang; Yuting Gou; Zhiying Wang; Dingyi Yang; Chong Li
Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations
Gastro Hep Advances 1(5) (2022)
Anton Gillessen; Francesco Angelico; Jun Chen; Lungen Lu; Maria Isabel Lucena; Qingchun Fu; Qing Xie; Raul J. Andrade; Wen Xie; Xiaoyuan Xu; Yanyan Yu; Yi-min Mao; Yuemin Nan
Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats
BMC Complementary Medicine and Therapies 21(1) (2021)
Tewodros Mengesha; Natesan Gnanasekaran; Tsegaye Mehare
Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease
Middle East Journal of Digestive Diseases 8(1) (2015)
Mohammad Ebrahim Ghamarchehreh; Nematollah Jonaidi-Jafari; Mohammad Bigdeli; Hossein Khedmat; Amin Saburi
Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study
Current Therapeutic Research 87 (2017)
Hiroshi Tobita; Shuichi Sato; Tatsuya Miyake; Shunji Ishihara; Yoshikazu Kinoshita
A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis
Clinical Gastroenterology and Hepatology 15(12) (2017)
Chan Wah Kheong; Nik Raihan Nik Mustapha; Sanjiv Mahadeva
Effects of a low-fat diet on the hepatic expression of adiponectin and its receptors in rats with NAFLD
Annals of Hepatology 14(1) (2015)
Hong Ma; Guo-Ping You; Fan Cui; Lu-Fang Chen; Xiang-Jiu Yang; Li-Gang Chen; Hua-Dong Lu; Wen-Qiang Zhang
Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals
Biomarkers in Disease: Methods, Discoveries and Applications (2017)
Arpita Basu; Paramita Basu; Timothy J. Lyons
An update on nonalcoholic fatty liver disease
Journal of the American Academy of Physician Assistants 27(7) (2014)
Daniel M. Provencher
Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
European Medical Journal (2016)
Alabagi Abdulla; Charity Reynolds; H Hesham A-Kader
Metformin and Probiotics Interplay in Amelioration of Ethanol‐Induced Oxidative Stress and Inflammatory Response in an In Vitro and In Vivo Model of Hepatic Injury
Mediators of Inflammation 2021(1) (2021)
Farhin Patel; Kirti Parwani; Dhara Patel; Palash Mandal
Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals
Biomarkers in Disease: Methods, Discoveries and Applications (2016)
Arpita Basu; Paramita Basu; Timothy J. Lyons
Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis
World Journal of Gastroenterology 23(27) (2017)
Camila Ribeiro de Avelar; Emile Miranda Pereira; Priscila Ribas de Farias Costa; Rosângela Passos de Jesus; Lucivalda Pereira Magalhães de Oliveira
Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: A triple-blind, randomized, placebo-controlled clinical trial
Clinical Nutrition ESPEN 63 (2024)
Bang-yan Li; Yue Xi; Yu-Ping Liu; Di Wang; Cheng Wang; Chao-gang Chen; Xiao-hong Fang; Zhong-xia Li; Yu-ming Chen
Sirt1 and Sirt6 Mediate Beneficial Effects of Rosiglitazone on Hepatic Lipid Accumulation
PLoS ONE 9(8) (2014)
Soo Jin Yang; Jung Mook Choi; Eugene Chang; Sung Woo Park; Cheol-Young Park
Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis
Postgraduate Medical Journal 94(1116) (2018)
Kannan Sridharan; Gowri Sivaramakrishnan; Reginald Paul Sequeira; Abdelaziz Elamin
Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes (在一种与人类肥胖以及糖尿病相关的动物模型肥沙鼠中，水飞蓟素具有拮抗代谢综合征进展、拮抗氧化应激增加以及拮抗肝脏脂肪变性的有益作用)
Journal of Diabetes 6(2) (2013)
Saida Bouderba; Carlos Sanchez‐Martin; Gloria R. Villanueva; Dominique Detaille; E. Ahmed Koceïr
Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism
Expert Review of Gastroenterology & Hepatology 8(4) (2014)
Samir Rouabhia; Natasa Milic; Ludovico Abenavoli
Har silibinin en plass i behandlingen av leversykdommer?
Tidsskrift for Den norske legeforening 134(4) (2014)
Gülen Arslan Lied; Odd Helge Gilja; Trygve Hausken
Effects of silymarin on metabolic syndrome: a review
Journal of the Science of Food and Agriculture 98(13) (2018)
Maryam Vahabzadeh; Nafise Amiri; Gholamreza Karimi
Association of Serum Ferritin and Inflammatory Biomarkers with Insulin Resistance in Chinese Type 2 Diabetes Mellitus Patients
Journal of Biomedical Research & Environmental Sciences 1(7) (2020)
P Paudel; S Zhang; B Guo; A Pannu; G Rasalingam; R Sah; B Desai; A Yin; C Gu; Y Yuan; L Chen; W Niu
Future therapy for non‐alcoholic fatty liver disease
Liver International 38(S1) (2018)
Danny Issa; Vaishali Patel; Arun J. Sanyal
The Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups
Journal of Gastroenterology and Hepatology 33(1) (2017)
Shiv Chitturi; Vincent Wai‐Sun Wong; Wah‐Kheong Chan; Grace Lai‐Hung Wong; Simon Kin‐Hung Wong; Jose Sollano; Yen‐Hsuan Ni; Chun‐Jen Liu; Yu‐Cheng Lin; Laurentius Adrianto Lesmana; Seung Up Kim; Etsuko Hashimoto; Masahide Hamaguchi; Khean‐Lee Goh; Jiangao Fan; Ajay Duseja; Yock Young Dan; Yogesh Chawla; Geoff Farrell; Henry Lik‐Yuen Chan
Silymarin Modulates Microbiota in the Gut to Improve the Health of Sow from Late Gestation to Lactation
Animals 12(17) (2022)
Shengyu Xu; Xiaojun Jiang; Xinlin Jia; Xuemei Jiang; Lianqiang Che; Yan Lin; Yong Zhuo; Bin Feng; Zhengfeng Fang; Jian Li; Jianping Wang; Zhihua Ren; De Wu
Effect of Medicinal Plants and Natural Products on Liver Enzymes in Non-alcoholic Fatty Liver Patients in Iran: A Systematic Review and Meta-Analysis
International Journal of Preventive Medicine 13(1) (2022)
Moloud Fakhri; Hafez Fakheri; Mohammad Azadbakht; Mahmood Moosazadeh; Seyde Sedighe Yousefi
Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
Pharmaceuticals 11(4) (2018)
Matteo Tacelli; Ciro Celsa; Bianca Magro; Aurora Giannetti; Grazia Pennisi; Federica Spatola; Salvatore Petta
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Clinical and Molecular Hepatology 28(3) (2022)
Han Ah Lee; Young Chang; Pil Soo Sung; Eileen L. Yoon; Hye Won Lee; Jeong-Ju Yoo; Young-Sun Lee; Jihyun An; Do Seon Song; Young Youn Cho; Seung Up Kim; Yoon Jun Kim
Should We Rely on the Findings of Each Published Randomized Controlled Study?
Hepatitis Monthly 13(3) (2013)
Ali Kabir
Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,
Clinics and Research in Hepatology and Gastroenterology 47(1) (2023)
Cai-yan Zou; Yan Sun; Jun Liang
Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
Canadian Liver Journal 7(1) (2024)
Adnan Malik; Muhammad Malik; Shahbaz Qureshi
Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta‐analysis of randomized controlled trials
Obesity Reviews 25(6) (2024)
Hao Wang; Qianqian Ma; Youpeng Chen; Ling Luo; Junzhao Ye; Bihui Zhong
Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease
Liver International 34(7) (2013)
Krzysztof Kurek; Dominika M. Piotrowska; Patrycja Wiesiołek‐Kurek; Bartłomiej Łukaszuk; Adrian Chabowski; Jan Górski; Małgorzata Żendzian‐Piotrowska
Non-alcoholic fatty liver disease: need for a balanced nutritional source
British Journal of Nutrition 112(11) (2014)
Jayagopalan Veena; Anjaneyulu Muragundla; Srinivas Sidgiddi; Swaminathan Subramaniam
Isolation and purification of diastereoisomeric flavonolignans from silymarin by binary‐column recycling preparative high‐performance liquid chromatography
Journal of Separation Science 37(17) (2014)
Weiquan Zhao; Guang Yang; Fanyi Zhong; Nan Yang; Xin Zhao; Yunpeng Qi; Guorong Fan
Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway
Pharmacological Reports 72(1) (2020)
Nuriye Ezgi Bektur Aykanat; Sedat Kacar; Serife Karakaya; Varol Sahinturk
Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of Silymarin
Gastroenterology Insights 12(2) (2021)
Ahmed Hashem; Yogesh Shastri; Malfi Al Otaibi; Elwin Buchel; Hussam Saleh; Reyaz Ahmad; Hamouda Ahmed; Fateh Al Idris; Saleh Ahmed; Mohamed Guda; Anton Gillessen
Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease
Medicine 97(37) (2018)
Jian-Hui Yan; Bing-Jie Guan; Hai-Yan Gao; Xian-E Peng
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis
Cochrane Database of Systematic Reviews 2021(7) (2021)
Oluyemi Komolafe; Elena Buzzetti; Audrey Linden; Lawrence MJ Best; Angela M Madden; Danielle Roberts; Thomas JG Chase; Dominic Fritche; Suzanne C Freeman; Nicola J Cooper; Alex J Sutton; Elisabeth Jane Milne; Kathy Wright; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
Diseases 6(3) (2018)
Brandon J. Perumpail; Andrew A. Li; Umair Iqbal; Sandy Sallam; Neha D. Shah; Waiyee Kwong; George Cholankeril; Donghee Kim; Aijaz Ahmed
The potential of silymarin for the treatment of hepatic disorders
Clinical Phytoscience 2(1) (2016)
Claus Hellerbrand; Jörn M. Schattenberg; Philipp Peterburs; Anja Lechner; Reto Brignoli
May Patients with Alcohol Liver Disease Benefit from Herbal Medicines?
Reviews on Recent Clinical Trials 11(3) (2016)
Natasa Milosevic; Maja Milanovic; Vesna Turkulov; Milica Medić-Stojanoska; Ludovico Abenavoli; Natasa Milic
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
World Journal of Gastroenterology 20(34) (2014)
Kareem Hassan
Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway
Digestive Diseases and Sciences 63(12) (2018)
Qiang Ou; Yuanyuan Weng; Siwei Wang; Yajuan Zhao; Feng Zhang; Jianhua Zhou; Xiaolin Wu
Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?
Annual Review of Pharmacology and Toxicology 56(1) (2016)
Swetha Rudraiah; Xi Zhang; Li Wang
The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease
Medicine 96(49) (2017)
Sheng Zhong; Yuxiang Fan; Qi Yan; Xingyu Fan; Bo Wu; Yujuan Han; Ying Zhang; Yong Chen; Huimao Zhang; Junqi Niu
Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)
Cochrane Database of Systematic Reviews 2017(4) (2017)
Rosa Lombardi; Simona Onali; Douglas Thorburn; Brian R Davidson; Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis
Sylimarin Versus Essential Phospholipids in Metabolic Associated Steatotic Liver Disease (MASLD) – A Prospective Comparative Randomized Trial
Maedica - A Journal of Clinical Medicine 1(1) (2024)
Teodora MANUC; Carmen Monica PREDA; Doina ISTRATESCU; Liana GHEORGHE; Razvan CERBAN; Carmen ESTER; Tudor Gheorghe STROIE; Raluca Ioana ALECU; Claudiu Mihai CIUCIUREANU; Alexandra Ioana MARIN; Letitia TUGUI; Cristian TIERANU; Sorin Lucian ANDREI; Mircea DICULESCU; Mircea MANUC
Temporal Relationship between Diet-Induced Steatosis and Onset of Insulin/Leptin Resistance in Male Wistar Rats
PLOS ONE 10(2) (2015)
Li Zhang; Haiyan Song; Yingli Ge; Guang Ji; Zemin Yao
A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease
Clinical Nutrition 40(5) (2021)
Laleh Mahmoudi; Sara Asadi; Zahra Al-Mousavi; Ramin Niknam
Mechanistic Insights into the Pharmacological Significance of Silymarin
Molecules 27(16) (2022)
Karan Wadhwa; Rakesh Pahwa; Manish Kumar; Shobhit Kumar; Prabodh Chander Sharma; Govind Singh; Ravinder Verma; Vineet Mittal; Inderbir Singh; Deepak Kaushik; Philippe Jeandet
Comparison of efficacy of anti-diabetics on non-diabetic NAFLD: A network meta-analysis
Frontiers in Pharmacology 13 (2023)
Dachuan Jin; Zhongfeng Cui; Shunqin Jin; Tao Zhou; Baoqiang Guo; Peng Gao; Guangming Li
Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
Scientia Pharmaceutica 91(4) (2023)
Saverio Nucera; Rosa Maria Bulotta; Stefano Ruga; Rosamaria Caminiti; Maria Serra; Roberto Bava; Fabio Castagna; Carmine Lupia; Mariangela Marrelli; Filomena Conforti; Giancarlo Statti; Vincenzo Mollace; Ernesto Palma
The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular)
Current Medicinal Chemistry 22(25) (2015)
Natalia Rosso; Veronica Marin; Antonio Giordani; Stefano Persiani; Federica Sala; Lucio Cavicchioli; Lucio Rovati; Claudio Tiribelli
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis
Antioxidants & Redox Signaling 26(10) (2017)
Schohraya Spahis; Edgard Delvin; Jean-Michel Borys; Emile Levy
Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials
Frontiers in Endocrinology 14 (2023)
Zeyu Wang; Huiqing Du; Ying Zhao; Yadi Ren; Cuihua Ma; Hongyu Chen; Man Li; Jiageng Tian; Caihong Xue; Guangfeng Long; Meidong Xu; Yong Jiang
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Journal of Diabetes Research 2023 (2023)
Fu Jianfang; Xiao Wanxia; Gao Xiling; Xu Jing; Yang Wenjuan; Liu Jianrong; He Qingzhen; Ma Kaiyan; Lian Jingxuan; Chen Taixiong; Xu Qian; Li Mengying; Ming Jie; Ji Qiuhe
Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease
Clinics in Liver Disease 20(2) (2016)
Swaytha Ganesh; Vinod K. Rustgi
The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review
European Journal of Clinical Pharmacology 80(1) (2023)
Maria Zachou; Pagona Flevari; Narjes Nasiri-Ansari; Constantinos Varytimiadis; Evangelos Kalaitzakis; Eva Kassi; Theodoros Androutsakos
Silybin Modulates Collagen Turnover in an In Vitro Model of NASH
Molecules 24(7) (2019)
Beatrice Anfuso; Pablo J. Giraudi; Claudio Tiribelli; Natalia Rosso
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
Best Practice & Research Clinical Gastroenterology 28(4) (2014)
Peter Dietrich; Claus Hellerbrand
Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial
Drug Research 73(04) (2023)
Manouchehr Khoshbaten; Samineh Beheshtirouy; Shahrzad Shayanrad; Afshin Gharekhani; Haleh Rezaee
Benefits of Combining Sonchus brachyotus DC. Extracts and Synbiotics in Alleviating Non-Alcoholic Fatty Liver Disease
Foods 12(18) (2023)
Wenwu Huang; Boyuan Shen; Xiumei Li; Tongcun Zhang; Xiang Zhou
Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD
Cell Biochemistry and Function 42(7) (2024)
Devaraj Ezhilarasan; Kulanthaivel Langeswaran
Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease
European Journal of Gastroenterology & Hepatology 29(12) (2017)
Malek Yaghoubi; Sattar Jafari; Behnam Sajedi; Sepehr Gohari; Samira Akbarieh; Amir H. Heydari; Maryam Jameshoorani
Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review
Journal of Medicinal Plants 1(73) (2020)
Sayed Mohammad Mohammadi; Saeed kianbakht; Shamsali Rezazadeh; Mojtaba Ziaee; Hasan Fallah Huseini
Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis
Acta Diabetologica 59(4) (2022)
Chen Ding; Yaxin Tang; Wenqiang Zhu; Piaopiao Huang; Pingan Lian; Juanli Ran; Xiansheng Huang
Impact of Silymarin Supplements on Liver Enzyme Levels: A Systematic Review
Cureus (2023)
Ernesto Calderon Martinez; Domenica Herrera; Saruveish Mogan; Zainab Hameed; Ayesha Altaf Jangda; Tayyaba J Khan; Palvi Mroke; Samar Sajid; Yash R Shah; Imran Baig
Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis
World Journal of Diabetes 12(9) (2021)
Yi-Zhou Huang; Gang-Yi Yang; Cong Wang; Xing-Yu Chen; Li-Li Zhang
Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways
European Journal of Pharmacology 887 (2020)
Lamiaa A. Ahmed; Maha B. Salem; Sayed H. Seif el-Din; Naglaa M. El-Lakkany; Hend O. Ahmed; Sami M. Nasr; Olfat A. Hammam; Sanaa S. Botros; Samira Saleh
Effects of different natural products in patients with non‐alcoholic fatty liver disease—A network meta‐analysis of randomized controlled trials
Phytotherapy Research 38(7) (2024)
Hongshuai Liu; Yufei Li; Yan Jin; Xin Li; Dongxian Wang; Xiaowen Yu; Zhenyuan Jiang; Guoliang Yin; Suwen Chen; Xin Zhang; Decheng Meng; Wenfei Yu; Wenyin Jiang; Fengxia Zhang
The Effects of Realsil (Silybin–Phospholipid–Vitamin E Complex) on Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steato-Hepatitis (NASH): a Systematic Review and Meta-Analysis of RCTS
Acta Endocrinologica (Bucharest) 16(2) (2020)
S Derakhshandeh-Rishehri
Diet and Lifestyle Changes as Treatment for Nonalcoholic Fatty Liver Disease
Liver Metabolism and Fatty Liver Disease (2014)
Silybin induces endothelium-dependent vasodilation via TRPV4 channels in mouse mesenteric arteries
Hypertension Research 45(12) (2022)
Xin Wen; Yidi Peng; Bohao Zheng; Shaying Yang; Jing Han; Fan Yu; Tingting Zhou; Li Geng; Zhiming Yu; Lei Feng